PTSD Progress Note and Privileged Note: Clinical Case Study
This paper presents a psychiatric progress note and privileged note for a 33-year-old African-American woman diagnosed with PTSD following intimate partner violence. After four weeks of treatment with Sertraline 25 mg and weekly cognitive behavioral therapy (CBT), the client shows minimal improvement. The paper documents her subjective complaints, clinical impressions, safety status, and psychosocial functioning. It then outlines revised treatment recommendations, including an increased Sertraline dosage, more frequent CBT sessions, and interdisciplinary collaboration with a nutritionist and family counselor. A separate privileged note addresses family dynamics, anger management, and self-esteem. The paper also distinguishes between progress notes and privileged notes under HIPAA privacy guidelines.
- Case Summary and Background: PTSD diagnosis and initial treatment overview
- Subjective Report and Treatment Compliance: Client's self-reported symptoms and medication adherence
- Clinical Impressions and Safety: Clinician observations and safety screening findings
- Analysis and Treatment Rationale: Evidence-based reasoning for maintaining Sertraline
- Revised Treatment Plan and Recommendations: Dosage increase, CBT frequency, and referrals
- Privileged Note: Family and Psychosocial Considerations: Private notes on family dynamics and self-esteem
- Progress Notes vs. Privileged Notes: Legal and clinical distinction between note types
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The case study follows a structured clinical documentation format — subjective content, objective findings, analysis, and plan — mirroring real-world psychiatric progress notes, which lends it professional authenticity.
- The paper integrates evidence-based rationale for treatment decisions, citing peer-reviewed literature on SSRI timelines and CBT session frequency to justify each recommendation.
- The privileged note section adds conceptual depth by distinguishing between two types of clinical documentation and explaining their different legal and ethical statuses under HIPAA.
Key academic technique demonstrated
The paper demonstrates clinical reasoning through the SOAP (Subjective, Objective, Assessment, Plan) documentation framework. Rather than simply describing symptoms, the writer connects clinical observations to evidence-based decisions, such as maintaining Sertraline rather than switching SSRIs because the six-to-eight-week therapeutic window has not elapsed. This shows the ability to apply biomedical and behavioral evidence to individualized patient care.
Structure breakdown
The paper is divided into two parts: a formal progress note (Part 1) and a privileged note (Part 2). Part 1 proceeds through standard clinical documentation sections — case summary, subjective content, compliance, psychosocial context, safety, clinical impressions, analysis, and plan. Part 2 addresses sensitive family information and explains the theoretical distinction between progress notes and privileged notes. Together, the two parts illustrate complete psychiatric case management documentation at the graduate clinical level.
Case Summary and Background
Client Y is a 33-year-old African-American female with two children aged 3 and 5, married to a 39-year-old Hispanic male. She presents following a referral by her sister, who believes she is under severe emotional distress. Symptoms at the time of presentation included depressed mood, inability to concentrate, nightmares, sleeping difficulties, and heightened irritability. The client reported that symptoms began four months earlier, after a violent encounter with her husband that resulted in serious injury.
Client Y was diagnosed with post-traumatic stress disorder (PTSD) and placed on Sertraline (Zoloft) 25 mg once daily in addition to once-weekly cognitive behavioral therapy (CBT) sessions. The goal of treatment is to ensure that Client Y regains control over her life and develops skills to address her symptoms. Four weeks later, the client shows minimal response to treatment, and PTSD symptoms remain present. No modifications have been made to the treatment plan thus far.
References
Bruijniks, S. E., Bosmans, J., Peters, F., & Huibers, M. (2015). Frequency and change mechanisms of psychotherapy among depressed patients: Study protocol for a multicenter randomized controlled trial comparing twice-weekly versus once-weekly sessions of CBT and IPT. BMC Psychiatry, 15(1), 137–147.
Corley, S. O. (2013). Protection for psychotherapy notes under HIPAA privacy rule: As private as a hospital gown. The Journal of Law-Medicine, 22(2), 489–534.
Fergusson, J. M. (2001). SSRI antidepressant medications: Adverse effects and tolerability. Primary Care Companion to the Journal of Clinical Psychiatry, 3(1), 22–27.
Sanchez, C., Reines, E. H., & Montgomery, S. (2014). A comparative review of escitalopram, paroxetine, and sertraline. International Clinical Psychopharmacology, 29(4), 185–196.
Shi, A., Atlantis, E., Taylor, A. W., Gill, T., Price, K., Appleton, S., Wong, M., & Licinio, J. (2017). SSRI antidepressant use potentiates weight gain in the context of unhealthy lifestyles: Results from a 4-year Australian follow-up. BMJ Open, 7(8).
Create your account
Always verify citation format against your institution’s current style guide requirements.